Afuco™ Anti-HGF ADCC Therapeutic Antibody (Ficlatuzumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human HGF. Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers.
Supplier Creative Biolabs
Product # AFC-TAB-749
Pricing Inquiry
Host Human
Target HGF
Species Reactivity Human
Type ADCC enhanced antibody
Applications ELISA, FC, IP, FuncS, IF, Neut
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback